Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 16 Oct 2017 |
2 | Reply to Exam Report (MIS-R) | 11 Dec 2017 |
3 | Letter | 17 May 2018 |
4 | Journal Copy | 02 Aug 2019 |
5 | TM-O(NOTICE OF OPPOSITION) | 31 Oct 2019 |
6 | Annexure -1 under rule 46 | 29 Oct 2020 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 29 Oct 2020 |
1 | Hearing Notice (Show Cause) | 8190788 | 4025825 | 30 Apr 2019 |
2 | Tribunal Accepted Notice for : 3658546 | 8440775 | 4158119 | 17 Jun 2019 |
3 | Opposition Notice | 9303290 | 4568346 | 26 Nov 2019 |
4 | Opposition Counter Statement | 9992238 | 4891443 | 01 May 2020 |
Trademark was applied on 16 October 2017 with IP India.
Proprietor of Engesto is MACKENZIE PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Engesto is Opposed.
Application number alloted to the trademark is 3658546.
S.S. Datta & Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD